Rating Scale

Related by string. * rated : Maintains Buy Rating / scales : Bobby Scales * ADHD Rating Scale . Rating Scale BPRS . Depression Rating Scale . Rating Scale MADRS . Hamilton Rating Scale . Rating Scale UPDRS . Mania Rating Scale . Anxiety Rating Scale . Pain Rating Scale . Parent Rating Scale . Parkinson Disease Rating Scale . Rating Scale IRLS . Numeric Rating Scale . Rating Scale ALSFRS R *

Related by context. All words. (Click for frequent words.) 71 Rating Scale MADRS 69 Montgomery Åsberg Depression 69 Rating Scale UPDRS 69 Montgomery Asberg Depression 67 Hamilton Rating Scale 67 Brief Psychiatric 67 PANSS 66 Unified Parkinson Disease 66 Depression Inventory 66 Depression Rating Scale 66 Health Assessment Questionnaire 65 UPDRS 64 Alzheimer Disease Assessment 64 subscales 64 Negative Syndrome 64 ADHD Rating Scale 64 Abnormal Involuntary Movement 63 Rating Scale BPRS 63 State Examination MMSE 63 Assessment Scale 62 MADRS 62 Depression Scale 62 YMRS 62 Global Impression CGI 62 ADAS cog 62 Global Impression 62 Symptom Checklist 61 Scale PANSS 61 HAM D 61 HAMD 61 Subscale 61 ADAS Cog 61 HAM D# 61 Scale Cognitive Subscale 60 symptom severity 60 Neuropsychiatric Inventory 60 Severity Index 60 subscores 60 QoL 60 Mania Rating Scale 60 Functional Assessment 59 IRLS 59 Anxiety Scale 59 Main Outcome Measures 59 Clinician Administered PTSD 59 ADCS CGIC 59 Visual Analog Scale 59 Expanded Disability Status 59 subscale 58 Psoriasis Area 58 HDRS 58 Child Behavior Checklist 58 HADS 58 Neuropsychiatric Inventory NPI 58 Distress Scale 58 Scale EDSS 58 Beck Anxiety Inventory 58 Depression Inventory BDI 57 Severity Index PASI 57 Scale 57 BMI z 57 Scale cognitive subscale 57 subscale scores 57 WOMAC 57 ADHD RS 57 Severity Scale 57 PANSS total 57 Visual Analogue Scale VAS 57 Brief Pain 57 Symptom Severity 57 Pain Rating Scale 57 Wechsler Intelligence 57 depressive symptom 57 Status Scale EDSS 57 IBDQ 56 QIDS SR 56 Index CDAI 56 Scale Revised 56 Hamilton Anxiety Scale 56 PANSS Positive 56 Numeric Rating Scale 56 MMSE 56 Outcomes Study 56 Depressive Symptomatology 56 Seattle Angina Questionnaire 56 mRS 56 Pain Intensity 56 APACHE II 56 subtest 56 subscore 56 pain subscale 56 Visual Analog 56 WAIS III 55 Y BOCS 55 Score TOS 55 Acute Physiology 55 MADRS score 55 Comorbidity 55 Mini Mental 55 NIH CPSI 55 Impressions Improvement 55 Symptom severity 55 Depressive Symptoms 55 et al #b 55 Treatment Outcome 55 Anxiety Rating Scale 54 Verbal Learning 54 HRQOL 54 Main Outcome Measure 54 State Trait Anxiety 54 Negative Symptoms 54 Obsessive Compulsive Scale 54 psychometric properties 54 EQ 5D 54 CNS LS 54 Glasgow Coma Scale 54 Crohn Disease Activity 54 cognitive affective 54 HAQ DI 54 Neuropsychological 54 ANOVA 54 Inventory BPI 54 BPRS 54 Symptom 54 Symptom Scale 54 WOMAC pain 54 interrater reliability 54 Index HAQ DI 54 DAS# scores 54 Score DAS 54 Anxiety Depression 54 International Prostate Symptom 54 Geriatric Depression 53 HRQL 53 Epworth Sleepiness Scale 53 retest reliability 53 Severity MSCS score 53 Disease Activity 53 Edinburgh Postnatal Depression 53 UPDRS Part III 53 Functioning GAF 53 NIS LL 53 premorbid 53 emotional lability 53 Depressive symptoms 53 FACIT Fatigue 53 NIHSS 53 WOMAC TM 53 psychosocial functioning 53 Functional Capacity 53 UPDRS motor 53 SF #v# 53 Interrater reliability 53 Chronic Illness Therapy 53 subtests 53 Severity 53 CDAI 53 DAS# [002] 52 Functioning Scale 52 Conflict Tactics 52 Cognitive Abilities Test 52 Bayley Scales 52 Hopkins Symptom Checklist 52 Primary endpoints 52 Mean Symptom Complex 52 Visual Analogue Scale 52 et al #a 52 magnetic resonance spectroscopic imaging 52 Wechsler Memory 52 RECIST Response Evaluation Criteria 52 Dyspnea 52 Adult ADHD 52 Depression Anxiety 52 Rosenberg Self Esteem 52 Score DAS# 52 HRQoL 52 Global Impression Severity 52 SGRQ 52 McGill Pain Questionnaire 52 function subscale 52 Index WOMAC 52 mTSS 52 bronchial hyperresponsiveness 52 Negative Symptom Scale 52 Symptom Score 52 Arm Shoulder 52 Prefrontal 51 Personality Questionnaire 51 PHQ 9 51 Clinical Dementia 51 Wechsler Adult 51 IIEF 51 Outcome Measures 51 Fibromyalgia Impact Questionnaire 51 Cognitive Function 51 Diagnostic Interview 51 depressive symptomatology 51 subjective sleepiness 51 Quotient TM 51 SELENA SLEDAI 51 Prognostic 51 Score IPSS 51 Predictors 51 untreated psychosis 51 Questionnaire 51 HOMA IR 51 Functional Outcomes 51 sd = 51 Cronbach 50 Stroke Scale 50 nasal symptom 50 Anthropometric 50 euthymic patients 50 Myocardial Perfusion 50 Assessment Questionnaire 50 ASIA Impairment 50 CIBIC plus 50 Risk Stratification 50 convergent validity 50 Respiratory Symptoms 50 Diagnostic Criteria 50 Sleep Disturbance 50 ALS Functional 50 Kruskal Wallis test 50 Heritability 50 daytime somnolence 50 Mental Component 50 PSQI 50 Cockcroft Gault 50 point Likert scale 50 Oswestry Disability Index 50 Prognostic Index 50 extrapyramidal symptoms 50 semistructured interview 50 symptomatology 50 Erectile Function 50 multivariate Cox 50 Secondary endpoints included 50 Ocular Surface Disease 50 comorbid anxiety 50 ADCS ADL 50 Cognitive Ability 50 SSRI citalopram 50 CFQ R 50 BILAG 49 MMSE score 49 CORE OM 49 Social Phobia 49 psychosocial variables 49 WISC IV 49 Scale EDSS score 49 psychiatric comorbidity 49 Cystic Fibrosis Questionnaire Revised 49 IPSS 49 TNSS 49 Correlates 49 Helps Relieve 49 Cognitive behavioral 49 bivariate 49 non menstrual pelvic 49 affective disorders 49 Subjective 49 neurobehavioral 49 somatic symptoms 49 Rating Scale IRLS 49 SDQ 49 Relieve Depression 49 intraclass correlation coefficient 49 Psychological Distress 49 Univariate 49 Postoperative 49 depressive symptoms 49 #q# deletion syndrome 49 VFQ 49 CIBIC + 49 EORTC QLQ C# 49 Maslach Burnout Inventory 49 Thrombolysis 49 parkinsonian 49 logistic regression analysis 49 State Exam MMSE 48 liver histology 48 univariate 48 Likert 48 neurocognitive 48 logistic regression 48 STAI 48 Ischemic Stroke 48 Meta Analysis 48 Orthostatic Hypotension 48 Lower Limb 48 NYHA functional class 48 interobserver 48 Likert type 48 apnea hypopnea index 48 Repeatable Battery 48 Physical Function 48 IKDC 48 ImPACT Immediate Post 48 Intervention Trial 48 Rheumatoid 48 Scale CNS 48 Self Efficacy 48 Neurobehavioral 48 Nutritional Status 48 Sexual Desire 48 semiquantitative 48 Renal Insufficiency 48 neurocognitive function 48 euthymic 48 Major Depressive Disorder 48 Neurodevelopmental 48 affective psychosis 48 Abdominal Pain 48 haematologic 48 KOOS 48 nerve conduction velocity 48 biopsy Gleason 48 Determinants 48 ALSFRS R 48 Left Ventricular 48 Panic Disorder 48 alexithymia 48 Secondary efficacy endpoints 48 logistic regression analyzes 48 DAS# CRP 48 Screening Questionnaire 48 secondary efficacy endpoint 47 POMS 47 Ashworth Scale 47 Assessment Tool 47 nonparametric 47 Index FSFI 47 Neuropsychological Status 47 Digit Symbol Substitution 47 odds ratios ORs 47 Psychiatric Disorders 47 subclinical atherosclerosis 47 Erectile Function IIEF 47 Academic Proficiency 47 Epidemiological Studies Depression 47 Socioeconomic Status 47 Secondary endpoints 47 intraclass correlation coefficients 47 multivariate analyzes 47 allele frequencies 47 Neurocognitive 47 â ‰ ¥ 47 Clinician Interview Based 47 IRLS score 47 Pathologic 47 CCyR 47 Subgroup Analysis 47 preoperative PSA 47 Endothelial function 47 fasting insulin 47 Secondary endpoints include 47 Glycemic Control 47 WOMAC scores 47 Laryngeal Cancer 47 Psychodynamic 47 Pharmacodynamic 47 intraobserver 47 Gunderson JG 47 variance ANOVA 47 Cardiovascular Risk 47 Follicular Lymphoma 47 PERMP 47 Insomnia Severity Index 47 psychomotor 47 estimated glomerular filtration 47 correlation coefficients 47 Total Nasal Symptom 47 Stanford Binet 47 df = 47 Cognitive Dysfunction 47 Pediatric Patients 47 DAS# remission 47 Personality Disorder 47 Injury Severity Score 47 albumin excretion rate 47 Epidemiologic Studies Depression 47 Nicotine Dependence 47 Generalized Anxiety Disorder 47 NPRS 47 Kruskal Wallis 47 Autistic Disorder 47 Comorbid 47 predictive validity 47 Inflammatory Pain 47 poststroke 47 imipramine Tofranil 47 inattention hyperactivity 47 Neuroticism 47 confidence intervals CIs 47 Histologic 46 unpaired t 46 demonstrated clinically meaningful 46 Standardized Assessment 46 binary logistic regression 46 Concussion Assessment 46 Impulsivity 46 Cronbach alpha 46 cortical atrophy 46 Prognostic Factors 46 Affective 46 Clinical Outcome 46 Ejection Fraction 46 Showed Significant 46 posttest 46 Obsessive Compulsive 46 Charlson Comorbidity Index 46 neuropsychological 46 Improves Outcomes 46 Cost Effectiveness 46 GERD symptom 46 Dissociation 46 hyperarousal 46 dyspnoea 46 Childhood Trauma 46 Suicidal ideation 46 ACR# ACR# 46 clinical meaningfulness 46 Treatment Diabetic Retinopathy 46 Hormone Levels 46 Node Negative 46 International Prognostic Scoring 46 Assessment 46 Adaptive Behavior 46 Solid Tumors 46 autonomic dysfunction 46 Stroke Scale NIHSS 46 Long Term Efficacy 46 DLQI 46 3rd edn 46 Not Otherwise Specified 46 hyperactivity inattention 46 rhinoconjunctivitis 46 comorbidity 46 attention-deficit/hyperactivity disorder 46 glomerular filtration rate 46 Effective Treatments 46 covariate 46 multivariable adjusted 46 Likert pain 46 chi squared 46 Magnetic Stimulation 46 pairwise comparisons 46 Predictive Value 46 BPH symptom 46 Timed Walk 46 Comorbidities 46 exhaled nitric oxide 46 Malignant Glioma 46 BI RADS 46 Endothelial Function 46 Regression 46 neuropsychological assessment 46 Loss Severity 46 multiple linear regression 46 Chronic Insomnia 46 Psychodynamic Psychotherapy 46 exploratory endpoints 46 clinicopathological features 46 internalizing behaviors 46 actigraphy 46 univariate analyzes 46 psychostimulants 46 guanfacine extended release 46 schizotypal 46 Systematic Review 45 Adjuvant Therapy 45 Insulin sensitivity 45 Wakefulness Test 45 Apgar scores 45 Tiotropium 45 Pharmacologic 45 EBMT criteria 45 Autism Diagnostic 45 Global Impressions Severity 45 Orally Active 45 overnight polysomnography 45 nonsignificant 45 Hepatic Encephalopathy 45 Screening Tool 45 cognitive behavioral 45 subthreshold depression 45 tryptophan depletion 45 Electrical Stimulation 45 bivariate analysis 45 Multiple Sleep Latency 45 p = .# [002] 45 suicide attempters 45 Left Ventricular Ejection Fraction 45 Thalamus 45 polyarticular 45 QIDS 45 Headache Disorders 45 serum IGF 45 Pharmacodynamics 45 PESQ 45 Psychomotor 45 DSM IV Axis 45 Wilcoxon rank sum 45 Academic Progress MAP 45 psychiatric morbidity 45 Digit Span 45 r = 45 Echocardiographic 45 CDAI score 45 conditional logistic regression 45 antidepressant monotherapy 45 Suicidality 45 Appropriateness Criteria 45 Logistic Regression 45 clinically meaningful improvement 45 Depression Scale HADS 45 Antipsychotic 45 Satisfaction Questionnaire 45 Hemoglobin A1c 45 somatostatin analog 45 leukocyte counts 45 Methylphenidate 45 prolactin elevation 45 multivariable analysis 45 OGTT 45 Posttraumatic 45 Solid Tumours 45 psychophysiological 45 = #.#-#.# 45 CONCERTA ® 45 erection hardness 45 Randomized Evaluation 45 Psychiatric Epidemiology 45 SGOT 45 Glomerular filtration rate 45 NIHSS score 45 MetS 45 logistic regression model 45 Somnolence 45 ANCOVA 45 Monotherapy 45 nondepressed 45 Diseases Ninth 45 ETDRS 45 Descriptive statistics 45 risperidone Risperdal 45 Septic Shock 45 Cystatin C 45 Systematic Treatment 45 Cognitive Impairment 45 Alzheimer Disease Cooperative 45 clinicopathological 45 ‰ ¥ 45 PCWP 45 Clinically meaningful 45 Conscientiousness 45 prospectively evaluated 45 urinary N telopeptide 45 fasting plasma glucose 45 Mortality Risk 45 Clinical Efficacy 45 achieved statistical significance 45 McMaster Universities Osteoarthritis 45 Lung Function 45 Multivariable 45 CRQ 45 Ischaemic 45 meta analytic 45 D Sequenced Treatment 45 electroencephalographic 45 mineral density BMD 45 hematologic parameters 45 multivariable Cox 45 CHADS 45 Escitalopram 45 PLMS 45 Disorders Identification 45 prespecified secondary 45 Shows Statistically Significant 45 juvenile idiopathic arthritis 44 glycosylated hemoglobin HbA1c 44 Selective serotonin reuptake inhibitors 44 C Reactive Protein 44 Glomerular Filtration Rate 44 serum prostate 44 Pervasive Developmental Disorder 44 somatoform disorders 44 Placebo Controlled Trial 44 Atomoxetine 44 Lower Extremity 44 Assesment 44 Analytical Reasoning 44 hemodynamic measurements 44 Antidepressant Treatment 44 Study Demonstrates 44 salivary cortisol 44 albumin excretion 44 Symptom Improvement 44 Hardness 44 enthesitis 44 Therapy Reduces 44 T2DM 44 Watchful Waiting 44 Fracture Risk 44 fluoxetine Prozac 44 Sociodemographic 44 Specificity 44 Impact Questionnaire 44 neurobehavioural 44 meta regression 44 glycosylated hemoglobin 44 Susceptibility 44 erythrocyte sedimentation rate 44 Cognitive Functioning 44 Preoperatively 44 fasting plasma 44 MMSE scores 44 clomipramine 44 sagittal abdominal diameter 44 comorbid depression 44 schizophrenia schizoaffective disorder 44 transcranial Doppler ultrasound 44 Angiographic 44 Patients Receiving 44 Perceptual 44 Cognitive 44 QOL 44 Demonstrated Significant 44 endometrial thickness 44 somatization 44 Adult Onset 44 Treating Chronic 44 Univariate analysis 44 trough FEV1 44 Significantly Improved 44 left ventricular LV 44 confirmed CCyR 44 Sleepiness 44 Severe Asthma 44 Adalimumab 44 Lesion 44 insulin resistance HOMA IR 44 idiopathic Parkinson disease 44 Pearson correlation coefficient 44 Coefficient 44 creatinine clearance 44 multivariate logistic regression 44 Patients Treated With 44 alanine aminotransferase ALT 44 function subscales 44 P = .# 44 Study Evaluating 44 Improves Quality 44 urodynamic parameters 44 Common Terminology Criteria 44 mg BID dose 44 Endocrine Therapy 44 Sensorimotor 44 Cardiac Function 44 postinjury 44 Fecal Incontinence 44 Stable Angina 44 Body Composition 44 Bone Metastases 44 Quantification 44 intima media thickness 44 Oral Fingolimod 44 Cardiac Resynchronization 44 Healthy Eating Index 44 Logistic regression 44 plasma cortisol 44 F FDG PET 44 Knee Osteoarthritis 44 generalized estimating 44 Assessment BCA 44 Newly Diagnosed Multiple Myeloma 44 Inhibitory 44 Cerebellar 44 Breast Cancer Recurrence 44 Kidney Function 44 icatibant 44 Non Responders 44 Autologous Stem Cell Transplantation 44 Brain Function 44 GH deficiency 44 Cognitive Abilities 44 DSM IV diagnoses 44 venlafaxine XR 44 Parkinsonian 44 comorbid disorders 44 Randomized Controlled Trials 44 Addiction Severity Index 44 Major Adverse Cardiac 44 Secondary Hyperparathyroidism 44 oral prednisolone 44 Oppositional Defiant Disorder 44 Negative Symptom Scale PANSS 44 Bonferroni correction 44 Cognitive Problems 44 Hormone Receptor Positive 44 Disease Progression 44 Prevalence 44 electrophysiologic 44 Node Positive 43 HbA 1c 43 dactylitis 43 Mutational 43 Female Sexual Function 43 Fasting Glucose 43 tic disorders 43 Proteinuria 43 Profile SEP 43 Cholinesterase Inhibitors 43 -#.# ± [002] 43 Ziprasidone 43 psychopathological symptoms 43 Desvenlafaxine Succinate 43 dichotomized 43 Heart Failure Patients 43 Framingham Offspring 43 posttreatment 43 Sexual Satisfaction 43 carotid IMT 43 Short Stature 43 Myocardial Infarction TIMI 43 RECIST criteria 43 Spectrum Disorders 43 Histological 43 Coronary Artery Bypass Surgery 43 Disord 43 repetitive transcranial magnetic stimulation 43 OSDI 43 Electrophysiological 43 hypochondriasis 43 impulsivity 43 Pearson correlation coefficients 43 histologic 43 dexamethasone suppression 43 MDRD 43 Non inferiority 43 postprocedure 43 Gene Linked 43 bivariate analyzes 43 Nerve Growth 43 Unstable Angina 43 Kellgren Lawrence 43 hepatic enzyme 43 Conduct Disorder 43 Developmental Disorders 43 Subtypes 43 Exposure Linked 43 Demonstrate Significant 43 Sexual Function 43 serum folate concentrations 43 Kaplan Meier analysis 43 primary aldosteronism 43 Myocardial Ischemia 43 Teduglutide 43 Differential Diagnosis 43 Chronic Renal Failure 43 histological 43 HPA axis 43 glycated hemoglobin HbA1c 43 Adiposity 43 Cognitive Behavioral Therapy 43 multiple logistic regression 43 lopinavir r arm 43 Bioavailability 43 psychiatric outpatients 43 intima media thickness IMT 43 Outcome 43 Communicative 43 venlafaxine Effexor 43 headache abdominal pain 43 eNO 43 CTEPH 43 Raven Progressive Matrices 43 Excretion 43 methotrexate monotherapy 43 Assigns LS 43 p = #.# [002] 43 cardiac autonomic 43 airway hyperresponsiveness 43 Study Casts Doubt 43 quetiapine Seroquel 43 TLUS 43 vasomotor 43 Index CDAI score 43 neuromotor 43 Epidemiologic Study 43 DSM IV diagnosis 43 PDSS 43 Parkinson Disease PD 43 Hypothalamic 43 Interpersonal Psychotherapy 43 ECLS 43 Treated Patients 43 Kaplan Meier estimates 43 Combination Treatment 43 aspartate aminotransferase AST 43 logit 43 Psychological Stress 43 Stimulation Therapy 43 Ischemic 43 EEG biofeedback 43 Aripiprazole 43 Severity Score 43 MSLT 43 neurophysiologic 43 PNES 43 Spasticity 43 Antipsychotics 43 Paced Auditory Serial 43 oxycodone CR 43 Interpersonal psychotherapy 43 System IPSS 43 Reading Fluency 43 Coronary Artery Calcium 43 Major Depressive 43 Metastatic Renal Cell Carcinoma 43 Platinol ® 43 highest tertile 43 Schizoaffective Disorder 43 generalized anxiety disorder GAD 43 Adverse Event 43 Erythema 43 hippocampal volume 43 Elastography 43 Thymic 43 coronary stenosis 43 accelerometry 43 Iron Deficiency Anemia 43 CYP#D# inhibitor 43 Atopic Dermatitis 43 Proves Effective 43 fructosamine 43 lumbar spine BMD 43 Adjunctive Therapy 43 Study Shows Significant 43 juvenile idiopathic arthritis JIA 43 Affective Disorders 43 fractional anisotropy 43 urinary albumin 43 Demonstrates Efficacy 43 orthostatic 43 Platelet Aggregation 43 Subgroup analysis 43 univariate analysis 43 Educational Progress exams 43 Behavior Problems 43 conduction velocity 43 Prostate Cancer Recurrence 42 Clinical Practice Guideline 42 epoetin alpha 42 Abdominal Fat 42 First Episode Psychosis 42 Contrast Enhancement 42 methacholine challenge 42 ropinirole Requip 42 AST ALT 42 autistic traits 42 Primary Endpoint 42 Adjuvant Treatment 42 Heart Rate Variability 42 Treatment Resistant 42 Health Questionnaire GHQ 42 CHADS2 42 serum cortisol 42 Visual acuity 42 Prognostic Value 42 Antisocial Personality Disorder 42 airway reactivity 42 Pharmacogenetic 42 Heterozygous Familial Hypercholesterolemia 42 Long Term Outcomes 42 Mouse Model 42 Combo Therapy 42 Histopathologic 42 Capsules CII 42 Zoloft sertraline 42 Mammographic 42 Neuropathic 42 verbal fluency 42 Strongly Linked 42 Eds. 42 Quotient 42 anthropometric measures 42 Nonalcoholic Fatty Liver Disease 42 Loading Dose 42 Metastatic Prostate Cancer 42 creatinine ratio 42 dopamine receptor gene 42 Clinical Outcomes 42 Maturity Level 5 42 Comparators 42 ST Segment Elevation 42 Treatment Approaches 42 interobserver reliability 42 PEPI 42 aminotransferase levels 42 ACER paper 42 Cognitive Deficits 42 Carotid Endarterectomy 42 Neurologic 42 placebo fluoxetine 42 Study Identifies 42 Apolipoprotein B 42 Polymorphism 42 Ventricular Arrhythmias 42 Statistically Significant 42 Demonstrates Sustained 42 Shows Efficacy 42 daytime alertness 42 decrements 42 longitudinal cohort study 42 covariance 42 Refractory Hodgkin Lymphoma 42 Prolongs Survival 42 Evaluable 42 Last Observation Carried 42 Virologic Response 42 myocardial viability 42 Significantly Improves 42 Homeostasis 42 Clinical Guideline 42 Reperfusion 42 arterial oxygen saturation 42 Circadian Clock 42 Gender Differences 42 attention-deficit/hyperactivity 42 covariates 42 Psychometric 42 Hypertrophy 42 Prevent Stroke 42 maximal treadmill 42 Helps Diagnose 42 triiodothyronine 42 Anti Tumor Activity 42 ALT AST 42 Complicated Grief 42 PsA 42 impulsivity characteristic 42 Poisson regression 42 Prophylactic Treatment 42 Blood Glucose 42 Sleep Patterns 42 Posttraumatic Stress 42 Vitamin D Linked 42 antiepileptics 42 Valvular 42 CGIC 42 glycated hemoglobin 42 Verbal Behavior 42 interrater 42 bivalirudin monotherapy 42 Non Alcoholic Steatohepatitis 42 lumbar spine bone 42 Bone Mineral Density 42 QD dosing 42 Mild Cognitive Impairment 42 Neuroprotection 42 Gene Mutation Linked 42 CLINICAL PHARMACOLOGY 42 reuptake inhibitor 42 Evoked 42 attention-deficit/hyperactivity disorder ADHD 42 Pharmacokinetic parameters 42 Haloperidol 42 daytime sleepiness 42 Psychosocial 42 DIBELS 42 Hyperlipidemia 42 CAHPS 42 Prostate Cancer Risk 42 Skin sterol 42 specific antigen PSA 42 morphometric 42 Quantitation 42 serum triglycerides 42 IELT 42 IQR 42 noncognitive 42 empirically derived 42 Agreeableness 42 Pharmacokinetic 42 Idiopathic 42 Efficacy endpoints 42 Low Incidence 42 highly heritable 42 QRS duration 42 Generalized 42 Adolescent Substance Abuse 42 Psychopathy 42 ± SD 42 Likert scale 42 Renal Function 42 neuropsychological deficits 42 Therapy Improves

Back to home page